Antibiotic Adjuvants: Make Antibiotics Great Again!

被引:211
作者
Douafer, Hana [1 ]
Andrieu, Veronique [2 ]
Phanstiel, Otto [3 ]
Brunel, Jean Michel [1 ]
机构
[1] Aix Marseille Univ, INSERM, SSA, MCT, F-13385 Marseille, France
[2] Aix Marseille Univ, Fac Med & Pharm, AP HM, IRD,MEPHI,IHU Mediterranee Infect, F-13385 Marseille, France
[3] Univ Cent Florida, Coll Med, 12722 Res Pkwy, Orlando, FL 32826 USA
关键词
OUTER-MEMBRANE PERMEABILITY; SPECTRUM BETA-LACTAMASES; MEDIATED DRUG-RESISTANCE; BACTERIAL OUTER; EFFLUX PUMP; ANTIMICROBIAL ACTIVITIES; ANTIBACTERIAL ACTIVITIES; POTENTIAL MANAGEMENT; MOLECULAR-MECHANISMS; STRATEGIES;
D O I
10.1021/acs.jmedchem.8b01781
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Multiple approaches have been developed to combat bacterial resistance. However, the combination of antibiotic resistance mechanisms by bacteria and the limited number of effective antibiotics available decreases the effective interventions for the treatment of current bacterial infections. This review covers the many ways that bacteria resist antibiotics including antibiotic target modification, the use of efflux pumps, and antibiotic inactivation. As a pertinent example, the use of beta lactamase inhibitors in combination with beta-lactam containing antibiotics is discussed in detail. The solution to emerging antibiotic resistance may involve combination therapies of existing antibiotics and potentiating adjuvants, which re-empower the antibiotic agent to become efficacious against the resistant strain of interest. We report herein that a reasoned adjuvant design permits one to perform polypharmacy on bacteria by not only providing greater internal access to the codosed antibiotics but also by de-energizing the efflux pumps used by the bacteria to escape antibiotic action.
引用
收藏
页码:8665 / 8681
页数:17
相关论文
共 114 条
[71]   Antibacterial activities and membrane permeability actions of glycinin basic peptide against Escherichia coli [J].
Li, Ying-Qiu ;
Sun, Xiu-Xiu ;
Feng, Jian-Ling ;
Mo, Hai-Zhen .
INNOVATIVE FOOD SCIENCE & EMERGING TECHNOLOGIES, 2015, 31 :170-176
[72]  
Lin J, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.00034, 10.1128/microbiolspec.VMBF-0016-2015]
[73]   ANTIMICROBIAL RESISTANCE OF STAPHYLOCOCCUS-AUREUS - GENETIC-BASIS [J].
LYON, BR ;
SKURRAY, R .
MICROBIOLOGICAL REVIEWS, 1987, 51 (01) :88-134
[74]   Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates [J].
Malléa, M ;
Mahamoud, A ;
Chevalier, J ;
Alibert-Franco, S ;
Brouant, P ;
Barbe, J ;
Pagès, JM .
BIOCHEMICAL JOURNAL, 2003, 376 :801-805
[75]   Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities [J].
Martins, Marta ;
Dastidar, Sujata G. ;
Fanning, Seamus ;
Kristiansen, Jette E. ;
Molnar, Joseph ;
Pages, Jean-Marie ;
Schelz, Zsuzsanna ;
Spengler, Gabriella ;
Viveiros, Miguel ;
Amaral, Leonard .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (03) :198-208
[76]   The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach? [J].
Melander, Roberta J. ;
Melander, Christian .
ACS INFECTIOUS DISEASES, 2017, 3 (08) :559-563
[77]   Molecular basis of bacterial outer membrane permeability revisited [J].
Nikaido, H .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2003, 67 (04) :593-+
[78]   Antibiotic efflux mechanisms [J].
Nikaido, H ;
Zgurskaya, HI .
CURRENT OPINION IN INFECTIOUS DISEASES, 1999, 12 (06) :529-536
[79]  
Nikaido H., 1996, COLI S TYPHIMURIUM, P29
[80]   β-lactamase inhibitors [J].
Page, MGF .
DRUG RESISTANCE UPDATES, 2000, 3 (02) :109-125